AASLD

The American Association for the Study of Liver Diseases (AASLD) is a leading organization of scientists and health care professionals committed to preventing and curing liver disease. AASLD was founded in 1950 by a group of leading liver specialists to bring together those who had contributed to the field of hepatology.

Beyond's analysis on AASLD

• 2026-10-08 — AusperBio to showcase long-term AHB-137 efficacy data at AASLD 2026

Recent news mentioning AASLD

• 2026-10-08 — AusperBio to Present Long-Term Follow-Up Data of AHB-137 Treatment in Chronic Hepatitis B in Two Late-Breaking Oral Presentations at AASLD The Liver Meeting® 2026
• 2026-10-06 — Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026
• 2026-10-06 — Inventiva présentera plusieurs abstracts scientifiques lors de l’AASLD The Liver Meeting® 2026
• 2026-10-06 — Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026
• 2026-10-05 — Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

Appears alongside

• AusperBio

Browse the full archive →